Emrosi Officially Launched for Treatment of Inflammatory Rosacea
Journey Medical has announced the launch and initial prescriptions for Emrosi for the treatment of inflammatory lesions of rosacea in adults.
According to a press release from the manufacturer, the minocycline hydrochloride modified-release capsule (40 mg) designed to treat inflammatory lesions of r...